Abstract No. 196: Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study

J.F Geschwind,R Lencioni,J Marrero,A Venook,S Ye,K Nakajima,M Kudo

doi:10.1016/j.jvir.2011.12.244

Abstract No. 196: Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study

J.F Geschwind, R Lencioni + Show 5 more

Open Access

https://doi.org/10.1016/j.jvir.2011.12.244

Copy DOI

Journal: Journal of Vascular and Interventional Radiology

Publication Date: Feb 27, 2012

Affiliation: Zhongshan Hospital, Bayer (United States), University of California, San Francisco, University of Pisa, Kindai University, University of Michigan–Ann Arbor

#Therapeutic Decisions In Hepatocellular Carcinoma #Global Investigation Of Therapeutic Decisions + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Abstract No. 196: Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study

Full Text